{"id":"W2975141952","doi":"10.1056/nejmoa1910962","title":"Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer","year":2019,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2262,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Eisai; Pacira BioSciences; Mylan; Clovis Oncology; Pacira Pharmaceuticals; Karyopharm Therapeutics; F. Hoffmann-La Roche; Roche; GlaxoSmithKline; Takeda Oncology; Amgen; Pfizer; Fujirebio US; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Ovarian cancer; Medicine; Oncology; Cancer; Gynecology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00113898,0.0003082164,0.001269807,0.0002093758,0.0001863167,0.000364899,0.0003512889,0.0004287466,0.00117931],"category_scores_gemma":[0.001509262,0.0001919348,0.0007243493,0.0002833315,0.00026011,0.0002604441,0.0002609626,0.000866364,0.0001536194],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000344233,"about_ca_system_score_gemma":0.000627664,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002627774,"about_ca_topic_score_gemma":0.0008610906,"domain_scores_codex":[0.9994987,0.0002749071,0.00004182446,0.00007487283,0.00006907805,0.00004057966],"domain_scores_gemma":[0.9989797,0.0003658697,0.0003355402,0.00004609647,0.00004576122,0.0002269216],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5091743,0.007413661,0.17917,0.003030421,0.00266639,0.001276986,0.0002257858,0.002638895,0.01913593,0.000289531,0.003765951,0.2712121],"study_design_scores_gemma":[0.3631995,0.2125725,0.392803,0.0003430932,0.002176027,0.007387235,0.0001573917,0.003468911,0.00505143,0.0007089557,0.01206452,0.00006738281],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9861812,0.01199664,0.000158136,0.0003090789,0.0001087017,0.0003097581,0.0002077031,0.00001816271,0.000710596],"genre_scores_gemma":[0.9953288,0.00296069,0.0004056371,0.0003250312,0.000130282,0.0002583632,0.0003337511,0.000002872242,0.0002545384],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001269807,"threshold_uncertainty_score":0.006023586,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01026469645237137,"score_gpt":0.2782807913748217,"score_spread":0.2680160949224503,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}